arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

Bon Natural Life Ltd

BON
$1.10 ▼ -0.01 (-0.90%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
6 Visible periods
7 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bon Natural Life Ltd faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Nov 3, 2026.

6-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Long-Term Debt Long-term obligations
$1.92M
↑ +34.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
20
Returns
40
Financial Health ↑
54
Cash Quality
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 6 quarters